Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
October 2014 Volume 34 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October 2014 Volume 34 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Silibinin protects β cells from glucotoxicity through regulation of the Insig-1/SREBP-1c pathway

  • Authors:
    • Ke Chen
    • Liling Zhao
    • Honghui He
    • Xinxing Wan
    • Fang Wang
    • Zhaohui Mo
  • View Affiliations / Copyright

    Affiliations: Department of Endocrinology, Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, P.R. China
  • Pages: 1073-1080
    |
    Published online on: August 8, 2014
       https://doi.org/10.3892/ijmm.2014.1883
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Exposure to high glucose may cause glucotoxicity, leading to pancreatic β cell dysfunction including cell apoptosis, impaired glucose‑stimulated insulin secretion (GSIS) and intracellular lipid accumulation. Sterol regulatory element binding protein-1c (SREBP-1c), a key nuclear transcription factor that regulates lipid metabolism, has been proven to play a role in insulin secretion. Insulin induced gene-1 (Insig-1) is an upstream regulatory factor of SREBP-1c. The overexpression of Insig-1 significantly inhibits SREBP-1c expression and thereby blocks the expression of downstream genes. It has been proven that silibinin, a natural flavanone, is involved in a variety of biological functions. In the present study, we examined whether silibinin protects high glucose-induced β cell dysfunction through the Insig-1/SREBP-1c pathway. Our data demonstrated that 30.0 µM of silibinin significantly improved cell viability (P<0.05) after rat insulinoma INS-1 cells were exposed to high glucose for 72 h. Silibinin partially attenuated GSIS following exposure to high glucose for either 24 or 72 h (both P<0.05). As shown by reverse transcription quantitative PCR, silibinin upregulated the mRNA expression of insulin secretion‑related genes [insulin receptor substrate 2 (IRS-2), pancreatic and duodenal homeobox 1 (PDX-1) and insulin], but downregulated uncoupling protein‑2 (UCP-2) expression. Silibinin inhibited intracellular lipid accumulation and free fatty acid (FFA) synthesis. Further experiments revealed that silibinin improved β cell function through the regulation of the Insig-1/SREBP-1c pathway. In conclusion, these results clearly suggest that the protection of β cells from glucotoxicity can be significantly enhanced through the regulation of the Insig-1/SREBP-1c pathway. Thus, silibinin may be a novel therapeutic agent for β cell dysfunction.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Imamura F, Mukamal KJ, Meigs JB, et al: Risk factors for type 2 diabetes mellitus preceded by β-cell dysfunction, insulin resistance, or both in older adults: the Cardiovascular Health Study. Am J Epidemiol. 177:1418–1429. 2013.

2 

Bensellam M, Laybutt DR and Jonas JC: The molecular mechanisms of pancreatic β-cell glucotoxicity: Recent findings and future research directions. Mol Cell Endocrinol. 364(1–2): 1–27. 2012.

3 

Kwon MJ, Chung HS, Yoon CS, et al: Low glibenclamide concentrations affect endoplasmic reticulum stress in INS-1 cells under glucotoxic or glucolipotoxic conditions. Korean J Intern Med. 28:339–346. 2013. View Article : Google Scholar

4 

Somesh BP, Verma MK, Sadasivuni MK, et al: Chronic glucolipotoxic conditions in pancreatic islets impair insulin secretion due to dysregulated calciumdynamics, glucose responsiveness and mitochondrial activity. BMC Cell Biol. 14:312013. View Article : Google Scholar

5 

Filhoulaud G, Guilmeau S, Dentin R, et al: Novel insights into ChREBP regulation and function. Trends Endocrinol Metab. 24:257–268. 2013. View Article : Google Scholar : PubMed/NCBI

6 

Jeon TI and Osborne TF: SREBPs: metabolic integrators in physiology and metabolism. Trends Endocrinol Metab. 23:65–72. 2012. View Article : Google Scholar : PubMed/NCBI

7 

Sandberg MB, Fridriksson J, Madsen L, et al: Glucose-induced lipogenesis in pancreatic beta cells is dependent on SREBP-1. Mol Cell Endocrinol. 240:94–106. 2005. View Article : Google Scholar : PubMed/NCBI

8 

Dong XY and Tang SQ: Insulin-induced gene: a new regulator in lipid metabolism. Peptides. 31:2145–2150. 2012. View Article : Google Scholar : PubMed/NCBI

9 

Chen K, Jin P, He HH, et al: Overexpression of Insig-1 protects β cell against glucolipotoxicity via SREBP-1c. J Biomed Sci. 18:572011.

10 

Gazák R, Walterová D and Kren V: Silybin and silymarin-new and emerging applications in medicine. Curr Med Chem. 14:315–338. 2007.PubMed/NCBI

11 

Huseini HF, Larijani B, Heshmat R, et al: The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial. Phytother Res. 20:1036–1039. 2006.

12 

Maghrani M, Zeggwagh NA, Lemhadri A, et al: Study of the hypoglycaemic activity of Fraxinus excelsior and Silybum marianum in an animal model of type 1 diabetes mellitus. J Ethnopharmacol. 91:309–316. 2004.

13 

Soto CP, Perez BL, Favari LP and Reyes JL: Prevention of alloxan-induced diabetes mellitus in the rat by silymarin. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 119:125–129. 1998. View Article : Google Scholar : PubMed/NCBI

14 

Matsuda T, Ferreri K, Todorov I, et al: Silymarin protects pancreatic beta-cells against cytokine-mediated toxicity: implication of c-Jun NH2-terminal kinase and janus kinase/signal transducer and activator of transcription pathways. Endocrinology. 146:175–185. 2005. View Article : Google Scholar

15 

Von Schönfeld J, Weisbrod B and Müller MK: Silibinin, a plant extract with antioxidant and membrane stabilizing properties, protects exocrine pancreas from cyclosporin A toxicity. Cell Mol Life Sci. 53:917–920. 1997.PubMed/NCBI

16 

Wang Q, Liu M, Liu WW, et al: In vivo recovery effect of silibinin treatment on streptozotocin-induced diabetic mice is associated with the modulations of Sirt-1 expression and autophagy in pancreatic β-cell. J Asian Nat Prod Res. 14:413–423. 2012.PubMed/NCBI

17 

Ka SO, Kim KA, Kwon KB, Park JW and Park BH: Silibinin attenuates adipogenesis in 3T3-L1 preadipocytes through a potential upregulation of the insig pathway. Int J Mol Med. 23:633–637. 2009.PubMed/NCBI

18 

Janowski BA: The hypocholesterolemic agent LY295427 up-regulates INSIG-1, identifying the INSIG-1 protein as a mediator of cholesterol homeostasis through SREBP. Proc Natl Acad Sci USA. 99:12675–1280. 2002. View Article : Google Scholar : PubMed/NCBI

19 

Kast-Woelbern HR, Dana SL, Cesario RM, et al: Rosiglitazone induction of Insig-1 in white adipose tissue reveals a novel interplay of peroxisome proliferator-activated receptor gamma and sterol regulatory element-binding protein in the regulation of adipogenesis. J Biol Chem. 279:23908–23915. 2004. View Article : Google Scholar

20 

Ma KL, Varghese Z, Ku Y, et al: Sirolimus inhibits endogenous cholesterol synthesis induced by inflammatory stress in human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol. 298:H1646–H1651. 2010. View Article : Google Scholar

21 

Nassuato G, Iemmolo RM, Strazzabosco M, et al: Effect of Silibinin on biliary lipid composition. Experimental and clinical study. J Hepatol. 12:290–295. 1991. View Article : Google Scholar : PubMed/NCBI

22 

Lupi R, Dotta F, Marselli L, et al: Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes. 51:1437–1442. 2002. View Article : Google Scholar

23 

Maedler K, Oberholzer J, Bucher P, et al: Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function. Diabetes. 52:726–733. 2003. View Article : Google Scholar : PubMed/NCBI

24 

Morgan D, Oliveira-Emilio HR, Keane D, et al: Glucose, palmitate and pro-inflammatory cytokines modulate production and activity of a phagocyte-like NADPH oxidase in rat pancreatic islets and a clonal beta cell line. Diabetologia. 50:359–369. 2006. View Article : Google Scholar : PubMed/NCBI

25 

Wang X, Li H, De Leo D, et al: Gene and protein kinase expression profiling of reactive oxygen species-associated lipotoxicity in the pancreatic beta-cell line MIN6. Diabetes. 53:129–140. 2004. View Article : Google Scholar : PubMed/NCBI

26 

Busch AK, Cordery D, Denyer GS and Biden J: Expression profiling of palmitate-and oleate-regulated genes provides novel insights into the effects of chroniclipid exposure on pancreatic beta-cell function. Diabetes. 51:977–987. 2002. View Article : Google Scholar : PubMed/NCBI

27 

Cunha DA, Hekerman P, Ladrière L, et al: Initiation and execution of lipotoxic ER stress in pancreatic beta-cells. J Cell Sci. 121:2308–2318. 2008. View Article : Google Scholar : PubMed/NCBI

28 

Bachar E, Ariav Y, Ketzinel-Gilad M, et al: Glucose amplifies fatty acid-induced endoplasmic reticulum stress in pancreatic beta-cells via activation of mTORC1. Plos One. 4:e49542009. View Article : Google Scholar : PubMed/NCBI

29 

Gwiazda KS, Yang TL, Lin Y and Johnson JD: Effects of palmitate on ER and cytosolic Ca2+ homeostasis in beta-cells. Am J Physiol Endocrinol Metab. 296:E690–E701. 2009. View Article : Google Scholar : PubMed/NCBI

30 

Shimano H, Amemiya-Kudo M, Takahashi A, et al: Sterol regulatory element-binding protein-1c and pancreatic beta-cell dysfunction. Diabetes Obes Metab. 9(Suppl 2): 133–139. 2007. View Article : Google Scholar : PubMed/NCBI

31 

Eizirik DL, Cardozo AK and Cnop M: The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev. 29:42–61. 2008. View Article : Google Scholar : PubMed/NCBI

32 

Amemiya-Kudo M, Oka J, Takeuchi Y, et al: Suppression of the pancreatic duodenal homeodomain transcription factor-1 (Pdx-1) promoter by sterol regulatory element-binding protein-1c (SREBP-1c). J Biol Chem. 286:27902–27914. 2011. View Article : Google Scholar

33 

Medvedev AV, Robidoux J, Bai X, et al: Regulation of the uncoupling protein-2 gene in INS-1 beta-cells by oleic acid. J Biol Chem. 277:42639–42644. 2002.PubMed/NCBI

34 

Sandberg MB, Bloksgaard M, Duran-Sandoval D, et al: The gene encoding acyl-CoA-binding protein is subject to metabolic regulation by both sterol regulatory element-binding protein and peroxisome proliferator-activated receptor alpha in hepatocytes. J Biol Chem. 280:5258–5266. 2005. View Article : Google Scholar

35 

Li J, Takaishi K, Cook W, McCorkle SK and Unger RH: Insig-1 ‘brakes’ lipogenesis in adipocytes and inhibits differentiation of preadi-pocytes. Proc Natl Acad Sci USA. 100:9476–9481. 2003.

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Chen K, Zhao L, He H, Wan X, Wang F and Mo Z: Silibinin protects β cells from glucotoxicity through regulation of the Insig-1/SREBP-1c pathway. Int J Mol Med 34: 1073-1080, 2014.
APA
Chen, K., Zhao, L., He, H., Wan, X., Wang, F., & Mo, Z. (2014). Silibinin protects β cells from glucotoxicity through regulation of the Insig-1/SREBP-1c pathway. International Journal of Molecular Medicine, 34, 1073-1080. https://doi.org/10.3892/ijmm.2014.1883
MLA
Chen, K., Zhao, L., He, H., Wan, X., Wang, F., Mo, Z."Silibinin protects β cells from glucotoxicity through regulation of the Insig-1/SREBP-1c pathway". International Journal of Molecular Medicine 34.4 (2014): 1073-1080.
Chicago
Chen, K., Zhao, L., He, H., Wan, X., Wang, F., Mo, Z."Silibinin protects β cells from glucotoxicity through regulation of the Insig-1/SREBP-1c pathway". International Journal of Molecular Medicine 34, no. 4 (2014): 1073-1080. https://doi.org/10.3892/ijmm.2014.1883
Copy and paste a formatted citation
x
Spandidos Publications style
Chen K, Zhao L, He H, Wan X, Wang F and Mo Z: Silibinin protects β cells from glucotoxicity through regulation of the Insig-1/SREBP-1c pathway. Int J Mol Med 34: 1073-1080, 2014.
APA
Chen, K., Zhao, L., He, H., Wan, X., Wang, F., & Mo, Z. (2014). Silibinin protects β cells from glucotoxicity through regulation of the Insig-1/SREBP-1c pathway. International Journal of Molecular Medicine, 34, 1073-1080. https://doi.org/10.3892/ijmm.2014.1883
MLA
Chen, K., Zhao, L., He, H., Wan, X., Wang, F., Mo, Z."Silibinin protects β cells from glucotoxicity through regulation of the Insig-1/SREBP-1c pathway". International Journal of Molecular Medicine 34.4 (2014): 1073-1080.
Chicago
Chen, K., Zhao, L., He, H., Wan, X., Wang, F., Mo, Z."Silibinin protects β cells from glucotoxicity through regulation of the Insig-1/SREBP-1c pathway". International Journal of Molecular Medicine 34, no. 4 (2014): 1073-1080. https://doi.org/10.3892/ijmm.2014.1883
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team